Shilpa Medicare informs about disclosure

21 Nov 2022 Evaluate
Shilpa Medicare has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November 18, 2022 for Deepak Kumar Innani.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

324.50 -1.45 (-0.44%)
17-Dec-2025 14:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.70
Dr. Reddys Lab 1269.70
Cipla 1493.90
Zydus Lifesciences 917.35
Lupin 2107.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×